Public Sector Pension Investment Board Coherus Bio Sciences, Inc. Transaction History

Public Sector Pension Investment Board

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.79 - $8.3 $19,632 - $42,994	5,180 Added 4.56%	118,708 $506,000
Q1 2023 May 12, 2023	SELL	$5.89 - $10.52 $31,935 - $57,039	-5,422 Reduced 4.56%	113,528 $776,000
Q1 2022 May 13, 2022	SELL	$10.92 - $16.41 $118,591 - $178,212	-10,860 Reduced 8.37%	118,950 $1.54 Million
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $24,347 - $29,244	1,540 Added 1.2%	129,810 $2.07 Million
Q3 2021 Nov 12, 2021	SELL	$12.68 - $17.79 $100,806 - $141,430	-7,950 Reduced 5.84%	128,270 $2.06 Million
Q2 2021 Aug 13, 2021	SELL	$12.95 - $15.41 $469,333 - $558,489	-36,242 Reduced 21.01%	136,220 $1.88 Million
Q1 2021 May 14, 2021	BUY	$14.42 - $21.39 $464,641 - $689,228	32,222 Added 22.98%	172,462 $2.52 Million
Q4 2020 Feb 12, 2021	BUY	$16.56 - $18.94 $16,560 - $18,940	1,000 Added 0.72%	140,240 $2.44 Million
Q3 2020 Nov 13, 2020	BUY	$17.41 - $19.89 $51,185 - $58,476	2,940 Added 2.16%	139,240 $2.55 Million
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $1.97 Million - $2.61 Million	136,300 New	136,300 $2.43 Million

130

67.8M

1.68M

91.8K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $71.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

Stay updated on Public Sector Pension Investment Board with notifications on news.